The important positive effect of IGF-1 on muscle mass was demonstrated in humans including community-dwelling middle-aged and elderly adults [30], and IGF-1 is considered as a promising therapeutic agent for sarcopenia resulted from aging or hypogonadism and muscle weakness from staving [31]. The gene discussed is IGF1; the disease is sarcopenia.